Ivan Spasojevic
Positions:
Associate Professor in Medicine
Medicine, Medical Oncology
School of Medicine
Member of the Duke Cancer Institute
Duke Cancer Institute
School of Medicine
Education:
Ph.D. 1999
Duke University
Grants:
The Role of IDH1 Mutations in Gliomagenesis and Metabolism
Administered By
Pathology
Awarded By
National Institutes of Health
Role
Co Investigator
Start Date
End Date
Biomarker Studies for Novel Anti-Cancer Agents
Administered By
Medicine, Medical Oncology
Awarded By
National Institutes of Health
Role
Research Associate
Start Date
End Date
Development of CaMKK2 inhibitor drug for acute radiation syndrome
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Columbia University
Role
Investigator
Start Date
End Date
Human EGFRvIII-specific BiTE for the treatment of Glioblastoma
Administered By
Neurosurgery
Awarded By
National Institutes of Health
Role
Investigator
Start Date
End Date
New therapeutic strategy in reversing radiation-induced erectile dysfunction with prostate cancer pa-tients
Administered By
Radiation Oncology
Awarded By
North Carolina Biotechnology Center
Role
Co Investigator
Start Date
End Date
Publications:
Mn porphyrin/ascorbate sensitizes serous epithelial ovarian cancer to chemotherapy
Authors
MLA Citation
Batinic-Haberle, Ines, et al. “Mn porphyrin/ascorbate sensitizes serous epithelial ovarian cancer to chemotherapy.” Free Radical Biology and Medicine, vol. 128, Elsevier BV, 2018, pp. S74–75. Crossref, doi:10.1016/j.freeradbiomed.2018.10.162.
URI
https://scholars.duke.edu/individual/pub1358453
Source
crossref
Published In
Free Radical Biology and Medicine
Volume
128
Published Date
Start Page
S74
End Page
S75
DOI
10.1016/j.freeradbiomed.2018.10.162
A PHASE I STUDY OF SINGLE-AGENT PERIFOSINE FOR RECURRENT/REFRACTORY PEDIATRIC CNS AND SOLID TUMORS
Authors
Millard, N; Becher, O; Modak, S; Haque, S; Spasojevic, I; Trippett, T; Gilheeney, S; Khakoo, Y; Lyden, D; De Braganca, K; Kolesar, J; Huse, J; Kramer, K; Dunkel, I
MLA Citation
Millard, Nathan, et al. “A PHASE I STUDY OF SINGLE-AGENT PERIFOSINE FOR RECURRENT/REFRACTORY PEDIATRIC CNS AND SOLID TUMORS.” Neuro Oncology, vol. 18, OXFORD UNIV PRESS INC, June 2016, pp. 25–25.
URI
https://scholars.duke.edu/individual/pub1024829
Source
wos
Published In
Neuro Oncology
Volume
18
Published Date
Start Page
25
End Page
25
Effects of fosaprepitan (Fosa) on ifosfamide (Ifex) metabolism in sarcoma patients (pts) receiving multi-day chemotherapy (CT) regimen on doxorubicin (Dox) and Ifex (AI): Randomized, cross-over study.
Authors
Vadhan-Raj, S; Ravi, V; Zhou, X; Araujo, DM; Somaiah, N; Conley, AP; Daniel, M; Benjamin, RS; Patel, S; Spasojevic, I
MLA Citation
Vadhan-Raj, Saroj, et al. “Effects of fosaprepitan (Fosa) on ifosfamide (Ifex) metabolism in sarcoma patients (pts) receiving multi-day chemotherapy (CT) regimen on doxorubicin (Dox) and Ifex (AI): Randomized, cross-over study.” Journal of Clinical Oncology, vol. 33, no. 15, AMER SOC CLINICAL ONCOLOGY, 2015.
URI
https://scholars.duke.edu/individual/pub1085185
Source
wos
Published In
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Volume
33
Published Date
Lipophilicity of Mn(III) N-Alkylpyridylporphyrins Dominates Their Accumulation Within Mitochondria and Therefore in Vivo Efficacy: a Mouse Study
Authors
Spasojevic, I; Miriyala, S; Tovmasyan, A; Salvemini, D; Fan, P; Vujaskovic, Z; Batinic-Haberle, I; Clair, DKS
MLA Citation
Spasojevic, Ivan, et al. “Lipophilicity of Mn(III) N-Alkylpyridylporphyrins Dominates Their Accumulation Within Mitochondria and Therefore in Vivo Efficacy: a Mouse Study.” Free Radical Biology and Medicine, vol. 51, Elsevier BV, 2011, pp. S98–99. Crossref, doi:10.1016/j.freeradbiomed.2011.10.473.
URI
https://scholars.duke.edu/individual/pub863917
Source
crossref
Published In
Free Radical Biology and Medicine
Volume
51
Published Date
Start Page
S98
End Page
S99
DOI
10.1016/j.freeradbiomed.2011.10.473
Pharmacokinetics of Cyclophosphamide in Scleroderma Treated By Cyclophosphamide Versus Transplantation
Authors
Adams, D; Sullivan, K; Spasojevic, I; Fan, P; Sampson, M; Cohen-Wolkowiez, M; St Clair, LW; Woolson, R; Storek, J; Csuka, ME; Pinckney, A; Welch, B; Goldmuntz, E; Furst, DE; Crofford, L; Keyes-Elstein, L; Mayes, M; McSweeney, P; Nash, R
MLA Citation
Adams, David, et al. “Pharmacokinetics of Cyclophosphamide in Scleroderma Treated By Cyclophosphamide Versus Transplantation.” Arthritis & Rheumatology, vol. 70, WILEY, 2018.
URI
https://scholars.duke.edu/individual/pub1356001
Source
wos
Published In
Arthritis & Rheumatology
Volume
70
Published Date
Associate Professor in Medicine
Contact:
5317 Orange Zone, Duke Hospital South, Durham, NC 27710
Box 3839 Med Ctr, Durham, NC 27710